Allan Reine is Chief Executive Officer of Prime Medicine, Inc. (PRME). The company reported total compensation of $3,894,187 for fiscal year 2025.
| Salary | $606,212 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $2,828,798 |
| Non-equity incentive plan | $402,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $57,177 |
| Total | $3,894,187 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Prime Medicine, Inc. filed April 23, 2026, accession 0001628280-26-026697.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Allan Reine this page | Chief Executive Officer | $3,894,187 |
| Keith Gottesdiener | Former Chief Executive Officer | $2,207,770 |
| Ann Lee | Chief Technical Officer | $1,550,116 |
| Jeremy Duffield | Former Chief Scientific Officer | $1,317,797 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Prime Medicine, Inc. compensation brief.
Allan Reine's compensation sits inside Prime Medicine, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.